PriceSensitive

Protech Home Medical (TSXV:PTQ) applies for NASDAQ listing

Sponsored
TSXV:PTQ
14 January 2021 10:07 (EDT)

Outpatient equipment provider Protech Home Medical (PTQ) is taking steps to list its common shares on the NASDAQ.

The company has made a formal application with the United States Securities and Exchange Commission (SEC).

That said, there is no assurance the company’s application will be approved.

“The submission of our application to list on the NASDAQ is a reflection of the tireless effort of the entire Protech team during a continued period of rapid growth for our company,” said chairman and CEO Greg Crawford.

“This marks a significant milestone in our Company’s lifecycle, and we are excited about substantially increasing our exposure and accessibility to the U.S. capital markets sphere and to U.S. based institutional and retail investors,” he added.

Protech is headquartered in Kentucky and provides home delivery and online set-up of equipment for primarily chronic conditions. The company operates out of 48 locations in 10 states with over 17,000 referring physicians and approximately 110,000 current active patients.

The company’s primary business objective is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management.

“A NASDAQ listing, coupled with our aggressive expansion plans is expected to continue to lead us down the path of becoming a premier technology driven clinical respiratory company in the United States,” Greg said.

Protech Home Medical opened 0.51 per cent up for C$1.96 per share at 10:02am EST.

Related News